Talnimate Tablets (Talniflumeate)

Adult dose

Administer 370 mg per dose orally 3 times daily as talniflumate. In severe cases, administer 740 mg per dose. The dosage may be adjusted according to age and symptoms.

This medication may cause serious side effects such as gastrointestinal bleeding in individuals who regularly consume more than three drinks a day, so consultation with a doctor or pharmacist is essential. This medication can affect the heart and blood vessels, potentially increasing the risk of cardiovascular diseases such as myocardial infarction or stroke. Special caution should be exercised in those with a history of cardiovascular disease or risk factors, and symptoms related to cardiovascular issues should be closely monitored during use. Additionally, this medication may cause serious gastrointestinal adverse reactions such as bleeding, ulcers, and perforation, so elderly patients or those with a history of gastrointestinal disease should be particularly cautious. If symptoms or pain of gastrointestinal bleeding occur during use, medical professionals should be notified immediately, and discontinuation of the medication may be necessary if warranted. This medication should not be administered to individuals with a history of peptic ulcers or allergies to this medication or its components, individuals who have experienced allergic reactions to aspirin or other non-steroidal anti-inflammatory drugs, individuals with severe liver, kidney, or heart disease, pregnant or breastfeeding women, and children under 12. Individuals with mild liver or kidney dysfunction, elderly patients, diuretic users, and those with a history of allergies to the dyes contained in this medication (Yellow No. 4, Yellow No. 5) should use this medication with caution. During treatment, side effects such as nausea, vomiting, diarrhea, abdominal pain, skin rashes, hives, dizziness, and blood pressure changes may occur so any abnormal symptoms should be reported to medical personnel immediately. It is advisable not to take this medication in conjunction with other anti-inflammatory analgesics, and it may interact with ACE inhibitors, aspirin, diuretics, lithium, methotrexate, anticoagulants, and other medications. Therefore, consultation with a healthcare provider is essential for patients taking these medicines. In late pregnancy, this drug may pose risks to the fetus; thus, pregnant women or those who could become pregnant should not take this medication, and breastfeeding mothers should discontinue breastfeeding or stop the medication if they take it. Elderly patients should use the minimum dose of this medication with caution and be particularly attentive to the occurrence of side effects. This medication should be kept out of the reach of children, and care should be taken not to transfer it to another container as it may compromise quality.

Dizziness, vomiting, photosensitivity, asthma attack, generalized weakness due to hypotension, hypersensitivity shock, diarrhea, abdominal distension, constipation, dyspepsia, ulcerative stomatitis, abdominal pain, hematemesis, colitis, exacerbation of Crohn's disease, gastrointestinal bleeding, peptic ulcer, perforation, hypertension, tachycardia, chest pain, arrhythmia, palpitations, hypotension, congestive heart failure, edema, hypertension, heart failure, vesicular reaction, Stevens-Johnson syndrome, Riel syndrome, rash, hives, pruritus, purpura, varicella-related skin and soft tissue infectious complications, dizziness, acute renal failure, interstitial nephritis, nephrotic syndrome, fluoride toxicity, abnormal liver function tests, thrombocytopenia

Store this medication in a tightly sealed container to protect it from air and moisture. It is advisable to maintain storage temperatures between 1 to 30 degrees Celsius.

Appearance

Yellow film-coated round tablets

Package unit

30 tablets/bottle, 500 tablets/bottle